Certara, Inc.

Status: Publicly traded

Direct answer

Certara, Inc. is publicly traded on NASDAQ under the ticker CERT.

Certara, Inc. provides advanced software solutions and technology-driven services, specializing in biosimulation throughout the entire drug development lifecycle. From initial drug discovery and preclinical research to clinical trials, regulatory submissions, and market entry, the company's core mission is to accelerate the delivery of new medicines to patients by transforming these processes with its innovative...

Can you invest in Certara, Inc.?

Yes. Certara, Inc. trades publicly on NASDAQ as CERT.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for Certara, Inc.

Detailed equity research is provided by MarketSnap.